Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS

NCT02933021 is registered in ClinicalTrials.gov with RxCelerate Ltd as lead sponsor.

NCT NCT02933021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02933021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS
Lead sponsor
RxCelerate Ltd
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2016
Completion date
February 28, 2021
Enrollment
664 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

monoclonal gammopathy of unknown significance